Carbidopa drug is given to people with Parkinson's disease to inhibit the peripheral metabolism of levodopa. It is a dopa decarboxylase inhibitor, and so it prevents the conversion of levodopa to dopamine. This property is significant because it allows a greater proportion of levodopa to cross the blood-brain barrier for the central nervous system effect.
Hello,Welcome to icliniq.comI understand your concern.Freezing of gait and increased falls in Parkinson's disease can be challenging, especially when early cognitive slowing is present.
Hi, Welcome to icliniq.com. I can understand your concern. You have raised very important and sensitive points, and these concerns are very real in women living with young-onset Parkinson’s.
Hello, Welcome to icliniq.com. I understand your concern. I do not understand what you mean by 'I made a mistake'.
Hello, Welcome to icliniq.com. I understand your concern. I am sorry to hear about your father's struggles.
Hello, Welcome to icliniq.com. I read your query and understand your concern.
Hello, Welcome to icliniq.com. I understand your concern. Based on what stage of her disease she is in, there are quite a few alternatives available for parkinsonism.
Hi, Welcome to icliniq.com. The medicines that you have been prescribed are perfectly fine.
Disclaimer: No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website. Read our Editorial Process to know how we create content for health articles and queries.
